Back
70
16
14
42
Also listed as
CPCAF
OTC
Day Range
$7.81
$8.13
52-Week Range
$5.48
$9.10
Volume
6,400
50D / 200D Avg
$8.11
/
$7.41
Prev Close
$7.90
Price History
Financial Trends
Peer Comparison
vs Industrials sector median (890 peers)
| Metric | Stock | Sector Median |
|---|---|---|
| P/E | 1.0 | 14.4 |
| P/B | 0.2 | 1.9 |
| ROE % | 19.2 | 11.3 |
| Net Margin % | 9.3 | 6.5 |
| Rev Growth 5Y % | 26.5 | 8.4 |
| D/E | 1.0 | 0.6 |
Key Takeaways
Revenue grew 26.45% annually over 5 years — strong growth
ROE of 19.20% — decent returns on equity
Generating 15.90B in free cash flow
P/E of 0.99 — trading at a low valuation
PEG of 0.70 suggests growth is underpriced
Revenue growth is decelerating — 1Y growth trails 5Y average by 14.76%
Growth
Revenue Growth (5Y)
26.45%
Revenue (1Y)11.69%
Earnings (1Y)9.32%
FCF Growth (3Y)-9.95%
Quality
Return on Equity
19.20%
ROIC8.84%
Net Margin9.27%
Op. Margin12.05%
Safety
Debt / Equity
0.98
Current Ratio0.38
Interest Coverage4.44
Valuation
P/E Ratio
0.99
P/B Ratio0.18
EV/EBITDA4.10
Dividend Yield0.06%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 11.69% | Revenue Growth (3Y) | 11.07% |
| Earnings Growth (1Y) | 9.32% | Earnings Growth (3Y) | 5.08% |
| Revenue Growth (5Y) | 26.45% | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | 116.57B | Net Income (TTM) | 10.81B |
| ROE | 19.20% | ROA | 6.11% |
| Gross Margin | 17.55% | Operating Margin | 12.05% |
| Net Margin | 9.27% | Free Cash Flow (TTM) | 15.90B |
| ROIC | 8.84% | FCF Growth (3Y) | -9.95% |
| Safety | |||
| Debt / Equity | 0.98 | Current Ratio | 0.38 |
| Interest Coverage | 4.44 | Dividend Yield | 0.06% |
| Valuation | |||
| P/E Ratio | 0.99 | P/B Ratio | 0.18 |
| P/S Ratio | 0.09 | PEG Ratio | 0.70 |
| EV/EBITDA | 4.10 | Dividend Yield | 0.06% |
| Market Cap | 10.73B | Enterprise Value | 57.54B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 116.57B | 104.37B | 94.49B | 51.04B | 45.59B |
| Net Income | 10.81B | 9.89B | 9.79B | -6.62B | -5.53B |
| EPS (Diluted) | 8.10 | 6.65 | 6.30 | -5.60 | -4.75 |
| Gross Profit | 20.46B | 32.58B | 20.70B | 20.41B | 3.17B |
| Operating Income | 14.05B | 13.93B | 15.13B | 3.47B | -1.44B |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 177.03B | 171.24B | 174.12B | 180.91B | 196.63B |
| Total Liabilities | 116.92B | 118.74B | 114.08B | 117.03B | 124.38B |
| Shareholders' Equity | 60.10B | 52.50B | 60.03B | 63.88B | 72.24B |
| Total Debt | 59.10B | 68.48B | 68.29B | 77.11B | 89.85B |
| Cash & Equivalents | 12.29B | 5.44B | 7.89B | 7.34B | 8.57B |
| Current Assets | 22.53B | 19.25B | 22.75B | 26.34B | 28.90B |
| Current Liabilities | 59.04B | 50.24B | 45.49B | 43.40B | 43.14B |
Strategy Scores
This stock passed the criteria for 4 strategies
Score = fit strength (0–100)
Rank = position among all matches
Custom
Cash Flow Compounder
#100 of 1024
#497 of 616
#492 of 658
Custom
Lower Risk
#87 of 136
Recent Activity
Entered
Cash Flow Compounder
Mar 24, 2026
Entered
Price/Sales Ratio Focus (Ken Fisher)
Mar 24, 2026
Entered
Contrarian Investing (David Dreman)
Mar 24, 2026
Entered
Lower Risk
Mar 24, 2026